CD274 and glioblastoma: CSCs express higher level of PD-L1 than non-CSCs, including in GBM, which in turn creates a positive feedback loop further increasing the stemness in tumor cells and inhibiting cytotoxic T cell activity via PD1/PD-L1 signaling (246–248).